πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 144 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11439658

Compositions and methods for suppressing MSUT2

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11414379

SPAK kinase inhibitors as neuroprotective agents

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11406646

Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acc

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11354990

Treatment of kidney diseases associated with elevated AVP

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11345894

Cellular seeding and co-culture of a three dimensional fibroblast construct

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11318190

Methods and compositions for treating liver disease

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11306122

Compositions and methods of inhibiting the binding of plasma IgG autoantibodies to seroton

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11291712

Bacterial protein compositions and uses thereof

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Apr 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11285154

Methods and compositions for treating cancer

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11278521

GAS5 binding compounds, formulations, and uses thereof

THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS OFFICE OF GENERAL COUNSELβ€”PSG IV (024) Β· Granted Tue Mar 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11274305

Compositions and methods for in vivo excision of HIV-1 proviral DNA

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11266676

MicroRNA in T cell activation

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11261152

Inhibitors of the N-terminal domain of the androgen receptor

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11260050

Combination of cotinine plus antioxidant for treatment-resistant depression and correction

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Mar 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11242339

Chemical inhibition of the E3 ligase subunit FBXO7 confers neuroprotection and anti-inflam

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11236340

Method of reducing the effects of aging-associated impairment of neurogenesis comprising m

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11173150

Method for diagnosing, preventing, and treating neurological diseases

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11160826

Cholesterol lowering drugs for the treatment of hepatic encephalopathy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Nov 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11141398

Methods for decreasing injuries associated with intraoperative hypotension

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Oct 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11110183

Method of delivering genes and drugs to a posterior segment of an eye

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11090313

Methods for inhibiting muscle atrophy

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Aug 17 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11072606

Compositions and methods for treating diseases and conditions

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11065254

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infec

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11040082

Compositions and methods for treating colorectal cancer

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted